As of March, 7 Analysts See $-0.35 EPS for Apollo Endosurgery, Inc. (APEN)

On March, 7 WallStreet anticipated Apollo Endosurgery, Inc. (NASDAQ:APEN)’s earnings report, as reported by Faxor. This year’s EPS analyst estimate is anticipated to be $-0.35. That is 16.67 % up compareed to $-0.42 EPS for last year. -22.22 % EPS growth is what Wall Street’s predicts after $-0.45 reported EPS previous quarter. Ticker’s shares touched $3.485 during the last trading session after 7.31% change.Currently Apollo Endosurgery, Inc. is downtrending after 7.09% change in last February 12, 2018. APEN has also 13,548 shares volume. The stock underperformed the S&P500 by 7.09%.

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for the treatment of obesity.The firm is valued at $76.30 million. The firm offers endo-bariatric products, such as Orbera intragastric balloon system, a non-surgical alternative for the treatment of overweight and obese adults; and OverStitch, an endoscopic suturing system that enables endoscopic procedures by allowing physicians to place full-thickness sutures and secure the approximation of tissue through an Olympus dual-channel flexible endoscope.Last it reported negative earnings. It also provides surgical products, including Lap-Band system, a system designed to provide minimally invasive long-term treatment of obesity; and accessories used in laparoscopic bariatric surgeries.

For more Apollo Endosurgery, Inc. (NASDAQ:APEN) news posted briefly go to: Businesswire.com, Seekingalpha.com, Seekingalpha.com, Businesswire.com or Seekingalpha.com. The titles are as follows: “Apollo Endosurgery Announces Presentation of Mayo Clinic’s Clinical Study of ORBERA┬« Intragastric Balloon in Patients with Nonalcoholic Steatohepatitis (NASH) at Digestive Disease Week┬« 2018 (DDW) – Business Wire” posted on June 05, 2018, “Apollo Endosurgery inks deal with Slater Endoscopy for the Ensizor Flexible Endoscopic Scissors – Seeking Alpha” on October 09, 2018, “Apollo Endosurgery announces the sale of its surgical product line – Seeking Alpha” with a publish date: December 18, 2018, “Apollo Endosurgery Announces Presentation of Mortality and Inpatient Costs of Revisional Bariatric Surgery – Business Wire” and the last “Apollo Endosurgery’s (APEN) CEO Todd Newton on Q3 2018 Results – Earnings Call Transcript – Seeking Alpha” with publication date: November 10, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.